Found 8 matching trials
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis PHASE2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate...
Show More Location
Dr. Sonia Kalirao
Learn More & Join Trial
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis PHASE2 This is a phase 2, multicenter, randomized, double-blind, placebo-controlle...
Show More Location
Del Sol Research Management, LLC
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis PHASE3 Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Effi...
Show More Status
Active Not Recruiting
Location
Neuro of Central Florida
Learn More & Join Trial
MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS) PHASE2 This is a Phase 2 multicenter, double-blind, placebo-controlled, randomized...
Show More Status
Active Not Recruiting
Location
MHAT Pulse AD, Department of Neurology Diseases
Learn More & Join Trial
Vidofludimus Calcium for Primary Sclerosing Cholangitis PHASE2 To examine the safety, tolerability, and efficacy of daily dosing with vido...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
IMU-838 and Oseltamivir in the Treatment of COVID-19 PHASE2 To evaluate whether time-to-improvement is significantly better in IMU-838 ...
Show More Location
University Hospital Coventry and Warwickshire NHS Trust
Learn More & Join Trial
A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) PHASE2 At present there is no approved drug treatment for Covid-19. In this study ...
Show More Location
Military Medical Academy, Clinic of Infectious Diseases
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis PHASE3 Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Effi...
Show More Status
Active Not Recruiting
Location
Xenoscience, Inc., 21st Century Neurology
Learn More & Join Trial